The pharmaceutical manufacturing industry is undergoing a period of major change, characterised by increased competition, industry globalisation and numerous mergers. The industry also faces multiple internal and external challenges such as high research and development costs, government regulations, and stringent manufacturing requirements. Thus, all biopharmaceutical companies are under the competing pressures of innovating, increasing growth and accelerating time-to-market while maintaining product quality.
Urch Publishing offers a unique report on this subject.
(0 items)
